Vanguard Group Inc Bluebird Bio, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 10,474,007 shares of BLUE stock, worth $3.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,474,007

Previous 10,301,300 1.68%

Holding current value

$3.35 Million

Previous $10.1 Million 46.05%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.47 - $1.35 $81,172 - $233,154	172,707 Added 1.68%	10,474,007 $5.45 Million
Q2 2024 Aug 13, 2024	SELL	$0.85 - $1.26 $167,586 - $248,421	-197,160 Reduced 1.88%	10,301,300 $10.1 Million
Q1 2024 May 10, 2024	BUY	$0.91 - $1.75 $1.57 Million - $3.02 Million	1,723,081 Added 19.64%	10,498,460 $13.4 Million
Q4 2023 Feb 14, 2024	BUY	$1.32 - $4.83 $4.17 Million - $15.3 Million	3,157,919 Added 56.22%	8,775,379 $12.1 Million
Q3 2023 Nov 14, 2023	BUY	$3.02 - $4.05 $139,572 - $187,174	46,216 Added 0.83%	5,617,460 $17.1 Million
Q2 2023 Aug 14, 2023	BUY	$2.79 - $5.03 $415,626 - $749,319	148,970 Added 2.75%	5,571,244 $18.3 Million
Q1 2023 May 15, 2023	BUY	$3.14 - $8.22 $3.63 Million - $9.5 Million	1,155,954 Added 27.09%	5,422,274 $17.2 Million
Q4 2022 Feb 10, 2023	BUY	$5.77 - $8.49 $3.21 Million - $4.73 Million	556,713 Added 15.01%	4,266,320 $29.5 Million
Q3 2022 Nov 14, 2022	BUY	$3.75 - $7.39 $760,117 - $1.5 Million	202,698 Added 5.78%	3,709,607 $23.5 Million
Q2 2022 Aug 12, 2022	SELL	$2.94 - $5.23 $7.12 Million - $12.7 Million	-2,420,647 Reduced 40.84%	3,506,909 $14.5 Million
Q1 2022 May 13, 2022	SELL	$4.07 - $10.6 $5.32 Million - $13.8 Million	-1,306,034 Reduced 18.06%	5,927,556 $28.7 Million
Q4 2021 Feb 14, 2022	BUY	$8.96 - $16.31 $1.29 Million - $2.35 Million	144,386 Added 2.04%	7,233,590 $72.3 Million
Q3 2021 Nov 12, 2021	BUY	$11.24 - $21.0 $1.44 Million - $2.69 Million	128,129 Added 1.84%	7,089,204 $135 Million
Q2 2021 Aug 13, 2021	BUY	$18.04 - $22.09 $126 Million - $154 Million	6,961,075 New	6,961,075 $223 Million

Others Institutions Holding BLUE

# of Institutions

152

Shares Held

63.7M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $24.7M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Bluebird Bio, Inc. Transaction History